What to Know About This $197,000 Veracyte Insider Sale After a 120% Stock Rally

Karin Eastham, a director of Veracyte (NASDAQ:VCYT), reported the sale of 3,729 shares of common stock in multiple open-market transactions on June 18, 2026, as detailed in the SEC Form 4 filing.

Post-transaction value (direct ownership)

Transaction value based on SEC Form 4 weighted average purchase price ($52.89); post-transaction value based on June 18, 2026 market close.

How does the size of this sale compare to Karin Eastham's prior selling activity?This 3,729-share sale is the smallest open-market disposition by Karin Eastham since June 2024, with recent sales averaging ~7,349 shares.

What percentage of direct holdings did this sale represent, and what does that imply for remaining capacity?The sale accounted for 20% of direct common holdings at the time of the transaction, leaving 15,097 shares.

Was there any indirect or derivative participation in this transaction?No; all shares sold were held directly, with no involvement of family trusts or derivative securities.

How does the timing and structure of this sale affect interpretation of insider intent?Because the transactions were executed pursuant to a pre-established Rule 10b5-1 plan, the sale should be viewed as rou

Fuente original: Yahoo Finance (https://finance.yahoo.com/markets/stocks/articles/know-197-000-veracyte-insider-170943813.html)